MDL-100250

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDL-100250
Drug Alias NameMDL-100250
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndopeptidases inhibitors
TargetsEndopeptidases
Therapy Area/IndicationsPainCardiovascular DiseasesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsPainCardiovascular DiseasesAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A